Additional 125 Billion Won Purchase Executed
Immediately After Acquiring 262 Billion Won in Shares
Celltrion Holdings, the holding company of the Celltrion Group, is accelerating its purchase of Celltrion shares on the open market, with a target amount of 500 billion won.
On September 8, Celltrion Holdings announced that it had completed on-market purchases of Celltrion shares worth approximately 262 billion won between August 7 and September 5, and has now begun acquiring an additional 125 billion won in shares. The additional share purchases will be conducted through on-market transactions from October 10 to November 7, 2025.
This decision follows the company's announcement in July to purchase Celltrion shares worth 500 billion won as part of efforts to improve profitability and enhance the corporate value of its subsidiaries. By securing additional shares in Celltrion, the holding company aims to improve its profitability through anticipated dividend increases and to support the enhancement of shareholder value for subsidiaries that are significantly undervalued relative to their intrinsic value.
Notably, Celltrion Holdings has already completed on-market purchases of Celltrion shares worth 262 billion won, exceeding the initially planned first-round amount of 250 billion won, and immediately proceeded with an additional purchase of 125 billion won, demonstrating its strong commitment to enhancing shareholder value. In April, the company also announced a plan to acquire shares worth 100 billion won and ultimately acquired shares worth 124 billion won.
Going forward, Celltrion Holdings intends to continue acquiring additional Celltrion shares up to the previously announced total of 500 billion won, in order to fulfill its commitment to shareholders and respond to share price volatility. If the market undervaluation persists, the company will consider injecting additional funds to further enhance subsidiary shareholder value. To support these shareholder value initiatives and restructuring of its business structure, Celltrion Holdings previously secured new funding of 1 trillion won.
Once Celltrion's corporate undervaluation eases and external uncertainties are resolved, the holding company plans to secure liquidity by selling the newly acquired shares in a manner that minimizes market impact, as part of efforts to accelerate business restructuring and improve capital efficiency. Shares previously held by the holding company, apart from the newly acquired portion, will not be sold and will remain as long-term holdings.
Additionally, Celltrion Holdings plans to maximize capital productivity and management efficiency as a holding company through business restructuring. This includes exploring options to transition from a pure holding company to an operating holding company, such as mergers and acquisitions with high-value domestic and overseas companies.
A Celltrion Group representative stated, "We are continuously working to maximize profitability and management efficiency in line with the roadmap for Celltrion Holdings' transition to an operating holding company. Celltrion remains undervalued relative to its intrinsic corporate value and has strong future growth potential, so this subsidiary share purchase is expected to secure future growth drivers for the holding company and lead to stable growth for the group."
Meanwhile, Celltrion is raising market expectations for the complete resolution of U.S. pharmaceutical tariff issues and continued growth in the second half of this year. Celltrion is currently finalizing a main contract for the acquisition of a biopharmaceutical production facility in the United States. Once the acquisition is complete, the company will be able to produce its key products sold in the U.S. locally, thereby fully avoiding pharmaceutical tariffs.
In terms of performance, Celltrion is optimizing its portfolio around high-margin new product lines, resulting in simultaneous growth in both sales and profits. The company has achieved its highest-ever quarterly operating profit since the merger, and plans to continue its strong growth trajectory in the second half of the year by launching high-margin new products and expanding into major global markets.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
